apo-gliclazide mr tablet (extended-release)
apotex inc - gliclazide - tablet (extended-release) - 60mg - gliclazide 60mg - sulfonylureas
mint-gliclazide mr tablet (extended-release)
mint pharmaceuticals inc - gliclazide - tablet (extended-release) - 30mg - gliclazide 30mg - sulfonylureas
mint-gliclazide mr tablet (extended-release)
mint pharmaceuticals inc - gliclazide - tablet (extended-release) - 60mg - gliclazide 60mg - sulfonylureas
mylan-gliclazide mr tablet (extended-release)
mylan pharmaceuticals ulc - gliclazide - tablet (extended-release) - 60mg - gliclazide 60mg - sulfonylureas
pharmacor gliclazide gliclazide 30 mg modified release tablet blister pack
pharmacor pty ltd - gliclazide, quantity: 30 mg - tablet, modified release - excipient ingredients: mannitol; hypromellose; sodium acetate; magnesium stearate; lactose monohydrate; silicon dioxide - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,during controlled clinical trials in patients with type ii diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.
pharmacor gliclazide mr gliclazide 60 mg modified release tablet bottle pack
pharmacor pty ltd - gliclazide, quantity: 60 mg - tablet, modified release - excipient ingredients: hypromellose; lactose monohydrate; sodium acetate; mannitol; magnesium stearate; silicon dioxide - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,during controlled clinical trials in patients with type ii diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.
pharmacor gliclazide mr gliclazide 60 mg modified release tablet blister pack
pharmacor pty ltd - gliclazide, quantity: 60 mg - tablet, modified release - excipient ingredients: mannitol; magnesium stearate; sodium acetate; silicon dioxide; hypromellose; lactose monohydrate - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,during controlled clinical trials in patients with type ii diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.
pharmacor gliclazide mr gliclazide 30 mg modified release tablet bottle pack
pharmacor pty ltd - gliclazide, quantity: 30 mg - tablet, modified release - excipient ingredients: hypromellose; magnesium stearate; silicon dioxide; sodium acetate; mannitol; lactose monohydrate - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,during controlled clinical trials in patients with type ii diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.
teva-gliclazide tablet
teva canada limited - gliclazide - tablet - 80mg - gliclazide 80mg - sulfonylureas
mylan-gliclazide tablet
mylan pharmaceuticals ulc - gliclazide - tablet - 80mg - gliclazide 80mg - sulfonylureas